Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.

Valent P, Sotlar K, Blatt K, Hartmann K, Reiter A, Sadovnik I, Sperr WR, Bettelheim P, Akin C, Bauer K, George TI, Hadzijusufovic E, Wolf D, Gotlib J, Mahon FX, Metcalfe DD, Horny HP, Arock M.

Leukemia. 2017 Apr;31(4):788-797. doi: 10.1038/leu.2017.15. Epub 2017 Jan 16. Review.

PMID:
28090091
2.

Degranulation Inhibitors from Medicinal Plants in Antigen-Stimulated Rat Basophilic Leukemia (RBL-2H3) Cells.

Matsuda H, Nakamura S, Yoshikawa M.

Chem Pharm Bull (Tokyo). 2016;64(2):96-103. doi: 10.1248/cpb.c15-00781. Review.

3.

[Therapy-related myelodysplastic syndrome as a late adverse event of definitive chemoradiotherapy for esophageal and oropharyngeal cancer].

Kamihara Y, Sato Y, Takada K, Okagawa Y, Iyama S, Sato T, Miyanishi K, Takimoto R, Kobune M, Kato J.

Nihon Shokakibyo Gakkai Zasshi. 2015;112(9):1664-73. doi: 10.11405/nisshoshi.112.1664. Review.

PMID:
26346357
4.

Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosis.

Horny HP, Sotlar K, Reiter A, Valent P.

Expert Rev Hematol. 2014 Aug;7(4):431-7. doi: 10.1586/17474086.2014.942280. Review.

PMID:
25025369
5.

Use of a rat basophil leukemia (RBL) cell-based immunological assay for allergen identification, clinical diagnosis of allergy, and identification of anti-allergy agents for use in immunotherapy.

Sun N, Zhou C, Zhou X, Sun L, Che H.

J Immunotoxicol. 2015 Apr-Jun;12(2):199-205. doi: 10.3109/1547691X.2014.920063. Epub 2014 Jun 12. Review.

PMID:
24920006

Supplemental Content

Loading ...
Support Center